check_circleStudy Completed

Bacterial Infection

Bayer Identifier:

Trial_1359

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Ciprofloxacin (sequential IV/PO, Intravenous/Peroral) in pediatric cystic fibrosis patients with acute pulmonary exacerbation

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

5 - 17 Years
  • -

  • -

Trial summary

Enrollment Goal
18
Trial Dates
August 1992 - August 1994
Phase
N/A
Could I Receive a placebo
N/A
Products
Cipro IV (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteer
N/A

Trial design

Pharmacokinetic determination of ciprofloxacin (sequential IV/PO, Intravenous/Peroral) in pediatric cystic fibrosis patients with acute pulmonary exacerbation
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A